127. 前頭側頭葉変性症 Frontotemporal lobar degeneration Clinical trials / Disease details

臨床試験数 : 90 / 薬物数 : 87 - (DrugBank : 30) / 標的遺伝子数 : 39 - 標的パスウェイ数 : 88

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-002251-11-ES (EUCTR)	31/01/2022	08/10/2021	A clinical study to learn whether a new drug, TPN-101, is safe when given to patients with amyotroph ...	A Phase 2a Study of TPN-101 in Patients with C9ORF72 ALS/FTD (Amyotrophic Lateral Sclerosis and/or F ...	Amyotrophic lateral sclerosis or frontotemporal dementia due to a genetic mutation called C9orf72 he ...	Product Name: TPN-101 Product Code: TPN-101 INN or Proposed INN: CENSAVUDINE	Transposon Therapeutics, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	France;United States;Canada;Belgium;Spain;Netherlands;Germany;United Kingdom
2	EUCTR2021-002251-11-DE (EUCTR)	06/12/2021	02/08/2021	A clinical study to learn whether a new drug, TPN-101, is safe when given to patients with amyotroph ...	A Phase 2a Study of TPN-101 in Patients with C9ORF72 ALS/FTD (Amyotrophic Lateral Sclerosis and/or F ...	Amyotrophic lateral sclerosis or frontotemporal dementia due to a genetic mutation called C9orf72 he ...	Product Name: TPN-101 Product Code: TPN-101 INN or Proposed INN: CENSAVUDINE	Transposon Therapeutics, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	40	Phase 2	France;United States;Canada;Spain;Belgium;Netherlands;Germany;United Kingdom

First Previous1Next Last